Kevin J. Hodgetts

1.0k total citations
32 papers, 769 citations indexed

About

Kevin J. Hodgetts is a scholar working on Molecular Biology, Organic Chemistry and Cellular and Molecular Neuroscience. According to data from OpenAlex, Kevin J. Hodgetts has authored 32 papers receiving a total of 769 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 9 papers in Organic Chemistry and 8 papers in Cellular and Molecular Neuroscience. Recurrent topics in Kevin J. Hodgetts's work include Neuroscience and Neuropharmacology Research (5 papers), Neurogenetic and Muscular Disorders Research (5 papers) and RNA modifications and cancer (5 papers). Kevin J. Hodgetts is often cited by papers focused on Neuroscience and Neuropharmacology Research (5 papers), Neurogenetic and Muscular Disorders Research (5 papers) and RNA modifications and cancer (5 papers). Kevin J. Hodgetts collaborates with scholars based in United States, Ireland and United Kingdom. Kevin J. Hodgetts's co-authors include Mark T. Kershaw, Elliot J. Androphy, Robbin Brodbeck, Stéphane De Lombaert, Chien‐liang Glenn Lin, Gregory D. Cuny, Marcie A. Glicksman, Xuechao Xing, Qiongman Kong and Kou Takahashi and has published in prestigious journals such as The Journal of Experimental Medicine, Annals of Neurology and Scientific Reports.

In The Last Decade

Kevin J. Hodgetts

31 papers receiving 740 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kevin J. Hodgetts United States 16 353 275 134 95 65 32 769
Andrew W. Stamford United States 22 479 1.4× 604 2.2× 245 1.8× 171 1.8× 187 2.9× 51 1.5k
Francesca Simorini Italy 23 703 2.0× 709 2.6× 142 1.1× 77 0.8× 158 2.4× 53 1.4k
Bertrand L. Chenard United States 15 235 0.7× 256 0.9× 257 1.9× 39 0.4× 67 1.0× 28 668
Masahiro Yonaga Japan 18 460 1.3× 324 1.2× 96 0.7× 40 0.4× 82 1.3× 35 922
Sung‐Hwa Yoon South Korea 16 133 0.4× 247 0.9× 160 1.2× 93 1.0× 154 2.4× 44 850
Mervyn Thompson United Kingdom 21 469 1.3× 387 1.4× 213 1.6× 212 2.2× 57 0.9× 44 1.1k
Shawn D. Doran United States 16 149 0.4× 272 1.0× 153 1.1× 99 1.0× 87 1.3× 20 747
Simon M. N. Efange United States 23 280 0.8× 767 2.8× 475 3.5× 83 0.9× 168 2.6× 69 1.4k
Alan Hutchison Switzerland 17 323 0.9× 388 1.4× 228 1.7× 34 0.4× 47 0.7× 24 761
Yewei Sun China 23 161 0.5× 403 1.5× 159 1.2× 170 1.8× 143 2.2× 58 1.2k

Countries citing papers authored by Kevin J. Hodgetts

Since Specialization
Citations

This map shows the geographic impact of Kevin J. Hodgetts's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kevin J. Hodgetts with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kevin J. Hodgetts more than expected).

Fields of papers citing papers by Kevin J. Hodgetts

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kevin J. Hodgetts. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kevin J. Hodgetts. The network helps show where Kevin J. Hodgetts may publish in the future.

Co-authorship network of co-authors of Kevin J. Hodgetts

This figure shows the co-authorship network connecting the top 25 collaborators of Kevin J. Hodgetts. A scholar is included among the top collaborators of Kevin J. Hodgetts based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kevin J. Hodgetts. Kevin J. Hodgetts is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Fanning, Saranna, Jooyoung Jeong, Joon Yoon, et al.. (2022). Lipase regulation of cellular fatty acid homeostasis as a Parkinson’s disease therapeutic strategy. npj Parkinson s Disease. 8(1). 74–74. 13 indexed citations
2.
Hodgetts, Kevin J., et al.. (2020). Short-duration splice promoting compound enables a tunable mouse model of spinal muscular atrophy. Life Science Alliance. 4(1). e202000889–e202000889. 1 indexed citations
3.
Osman, Erkan Y., Rachel Kline, Jonathan J. Cherry, et al.. (2019). Intraperitoneal delivery of a novel drug‐like compound improves disease severity in severe and intermediate mouse models of Spinal Muscular Atrophy. Scientific Reports. 9(1). 1633–1633. 6 indexed citations
4.
Zhao, Fangli, Xueqin Wang, Zan Xu, et al.. (2018). Pyridazine-derivatives Enhance Structural and Functional Plasticity of Tripartite Synapse Via Activation of Local Translation in Astrocytic Processes. Neuroscience. 388. 224–238. 15 indexed citations
5.
Choi, Sung‐Woon, Hongxia Li, Jonathan J. Cherry, et al.. (2017). Optimization of a series of heterocycles as survival motor neuron gene transcription enhancers. Bioorganic & Medicinal Chemistry Letters. 27(23). 5144–5148. 3 indexed citations
6.
Androphy, Elliot J., et al.. (2016). Small Molecules in Development for the Treatment of Spinal Muscular Atrophy. Journal of Medicinal Chemistry. 59(22). 10067–10083. 53 indexed citations
7.
Hodgetts, Kevin J., Charles A. Blum, Timothy M. Caldwell, et al.. (2010). Pyrido[2,3-b]pyrazines, discovery of TRPV1 antagonists with reduced potential for the formation of reactive metabolites. Bioorganic & Medicinal Chemistry Letters. 20(15). 4359–4363. 10 indexed citations
8.
Blum, Charles A., Xiaozhang Zheng, Harry L. Brielmann, et al.. (2008). Aminoquinazolines as TRPV1 antagonists: Modulation of drug-like properties through the exploration of 2-position substitution. Bioorganic & Medicinal Chemistry Letters. 18(16). 4573–4577. 13 indexed citations
9.
Chandrasekhar, Jayaraman, David C. Ihle, David J. Wustrow, et al.. (2008). 1-Benzylbenzimidazoles: The discovery of a novel series of bradykinin B1 receptor antagonists. Bioorganic & Medicinal Chemistry Letters. 18(18). 5027–5031. 9 indexed citations
10.
Yoon, Tae‐young, Stéphane De Lombaert, Robbin Brodbeck, et al.. (2008). 2-Arylpyrimidines: Novel CRF-1 receptor antagonists. Bioorganic & Medicinal Chemistry Letters. 18(16). 4486–4490. 8 indexed citations
11.
Zheng, Xiaozhang, Kevin J. Hodgetts, Harry L. Brielmann, et al.. (2006). From arylureas to biarylamides to aminoquinazolines: Discovery of a novel, potent TRPV1 antagonist. Bioorganic & Medicinal Chemistry Letters. 16(19). 5217–5221. 25 indexed citations
12.
Hodgetts, Kevin J.. (2005). Inter- and intramolecular Mitsunobu reaction based approaches to 2-substituted chromans and chroman-4-ones. Tetrahedron. 61(28). 6860–6870. 62 indexed citations
13.
Hodgetts, Kevin J. & Mark T. Kershaw. (2003). Synthesis of 2-Aryl-oxazolo[4,5-c]quinoline-4(5H)-ones and 2-Aryl-thiazolo[4,5-c]quinoline-4(5H)-ones. Organic Letters. 5(16). 2911–2914. 54 indexed citations
14.
Hodgetts, Kevin J., Tae‐young Yoon, Jianhua Huang, et al.. (2003). 2-Aryl-3,6-dialkyl-5-dialkylaminopyrimidin-4-ones as novel crf-1 receptor antagonists. Bioorganic & Medicinal Chemistry Letters. 13(15). 2497–2500. 14 indexed citations
15.
Yuan, Jun, et al.. (2002). 3-Aryl pyrazolo[4,3-d]pyrimidine derivatives. Bioorganic & Medicinal Chemistry Letters. 12(16). 2133–2136. 30 indexed citations
16.
Zhao, He, Andrew Thurkauf, Kevin J. Hodgetts, et al.. (2002). Indoline and piperazine containing derivatives as a novel class of mixed D2/D4 receptor antagonists. Part 1: Identification and structure–activity relationships. Bioorganic & Medicinal Chemistry Letters. 12(21). 3105–3109. 21 indexed citations
17.
Hodgetts, Kevin J., et al.. (2001). 6-(4-Benzylpiperazin-1-yl)benzodioxanes as selective ligands at cloned primate dopamine D4 receptors. Bioorganic & Medicinal Chemistry. 9(12). 3207–3213. 17 indexed citations
18.
Carter, Rich G., et al.. (2000). Studies on the Stereoselective Synthesis of the Marine Antitumor Agent Eleutherobin. Tetrahedron. 56(26). 4367–4382. 40 indexed citations
19.
20.
Hodgetts, Kevin J., Christopher J. Wallis, & Timothy W. Wallace. (1995). Enantiocomplementary Routes to 6-Oxygenated (2Z,4E)-Alkadiene Precursors via Diastereoselective Reduction of 2-Cyclobuten-1-yl ketones. Synlett. 1995(12). 1235–1236. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Andrew W. Stamford Breakdown of academic impact, for papers by Francesca Simorini Breakdown of academic impact, for papers by Bertrand L. Chenard Breakdown of academic impact, for papers by Masahiro Yonaga Breakdown of academic impact, for papers by Sung‐Hwa Yoon Breakdown of academic impact, for papers by Mervyn Thompson Breakdown of academic impact, for papers by Shawn D. Doran Breakdown of academic impact, for papers by Simon M. N. Efange Breakdown of academic impact, for papers by Alan Hutchison Breakdown of academic impact, for papers by Yewei Sun
Rankless by CCL
2026